All articles by Derek Lowe – Page 8
-
-
Opinion
Knowledge lost or time gained?
Derek Lowe wonders whether we should mourn the decline of classic analytical techniques or embrace technological advances
-
Opinion
Lab’s labourers lost?
How long should scientists stay at the bench, asks Derek Lowe. How long is a piece of string?
-
Opinion
Target acquired
Knowing a drug’s exact biochemistry has never been a prerequisite for approval, says Derek Lowe, and nor should it be
-
Opinion
Bespoke or bodged
A can-do attitude and some lateral thinking can save time and money when it comes to exotic apparatus, says Derek Lowe
-
Opinion
From lab to leader
Derek Lowe asks (with some trepidation): do drug companies need scientists at the top?
-
Opinion
New antibiotics: what's the hold up?
It’s more a research problem, than a commercial one, says Derek Lowe
-
Opinion
Name reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Opinion
Fear of the unknown
How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
-
Opinion
Full disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
-
Opinion
High finance meets big pharma?
Derek Lowe examines an alternative funding model for pharmaceutical research
-
-
-
-
-
Opinion
Peace, love and understanding
Chemists and biologists often view the process of drug discovery very differently
-
Opinion
The elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come